...is there a legit potential to improve upon efficacy and safety of existing HAE drugs or is the development of an oral treatment likely to only offer incremental improvement and really just be more of a convenience advantage at best?
My guess is the latter, but I'm not especially well versed on the HAE arena.
“The efficient-market hypothesis may be the foremost piece of B.S. ever promulgated in any area of human knowledge!”